Agios Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	37.04	36.5	26.82	14.24	-	-	Upgrade
Revenue Growth (YoY)	25.96%	36.07%	88.36%	-	-	-	Upgrade
Cost of Revenue	310.03	305.45	298.41	281.61	256.97	220.81	Upgrade
Gross Profit	-273	-268.95	-271.58	-267.37	-256.97	-220.81	Upgrade
Selling, General & Admin	167.3	156.78	119.9	121.67	121.45	115.11	Upgrade
Operating Expenses	167.3	156.78	119.9	121.67	121.45	115.11	Upgrade
Operating Income	-440.29	-425.74	-391.49	-389.05	-378.42	-335.92	Upgrade
Interest & Investment Income	55.28	48.08	33.34	12.79	0.84	6.61	Upgrade
Other Non Operating Income (Expenses)	6.11	6.49	6.06	16.6	21.07	-	Upgrade
EBT Excluding Unusual Items	-378.91	-371.17	-352.09	-359.65	-356.51	-329.31	Upgrade
Gain (Loss) on Sale of Assets	200	200	-	-	-	-	Upgrade
Other Unusual Items	889.14	889.14	-	127.85	-	-	Upgrade
Pretax Income	710.23	717.97	-352.09	-231.8	-356.51	-329.31	Upgrade
Income Tax Expense	44.24	44.24	-	-	-	-	Upgrade
Earnings From Continuing Operations	665.99	673.73	-352.09	-231.8	-356.51	-329.31	Upgrade
Earnings From Discontinued Operations	-	-	-	-	1,961	1.94	Upgrade
Net Income	665.99	673.73	-352.09	-231.8	1,605	-327.37	Upgrade
Net Income to Common	665.99	673.73	-352.09	-231.8	1,605	-327.37	Upgrade
Shares Outstanding (Basic)	57	57	56	55	60	69	Upgrade
Shares Outstanding (Diluted)	58	58	56	55	60	69	Upgrade
Shares Change (YoY)	3.98%	4.02%	1.57%	-9.36%	-12.39%	15.01%	Upgrade
EPS (Basic)	11.67	11.86	-6.33	-4.23	26.55	-4.74	Upgrade
EPS (Diluted)	11.45	11.64	-6.33	-4.23	26.55	-4.74	Upgrade
Free Cash Flow	-403.77	-391.53	-297.06	-314.36	-413.06	-304.87	Upgrade
Free Cash Flow Per Share	-6.94	-6.76	-5.34	-5.74	-6.83	-4.42	Upgrade
Operating Margin	-1188.86%	-1166.47%	-1459.52%	-2732.07%	-	-	Upgrade
Profit Margin	1798.26%	1845.92%	-1312.63%	-1627.82%	-	-	Upgrade
Free Cash Flow Margin	-1090.25%	-1072.73%	-1107.49%	-2207.58%	-	-	Upgrade
EBITDA	-434.71	-420.08	-384.86	-380.48	-369.18	-326.13	Upgrade
D&A For EBITDA	5.58	5.65	6.62	8.56	9.24	9.79	Upgrade
EBIT	-440.29	-425.74	-391.49	-389.05	-378.42	-335.92	Upgrade
Effective Tax Rate	6.23%	6.16%	-	-	-	-	Upgrade
Revenue as Reported	37.04	36.5	26.82	14.24	-	-	Upgrade

Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q